Solo, 21 October 2025 - PT. Kalbe Farma Tbk. (Kalbe) has once again received an award for its efforts in continuing its commitment to sustainability from the Indonesian Health Services Association (ADINKES). The 2025 CSR PP ATM Award is clear evidence of Kalbe's concern for the nation's health. This achievement was awarded to Kalbe for its contributions in the prevention and control of AIDS, Tuberculosis, and Malaria (ATM).
Kalbe's Head of Corporate Sustainability, Abi Nisaka, received the CSR PP ATM Award 2025 on Tuesday, 21 October 2025, in Solo. The award ceremony, organised by the Indonesian Health Services Association (ADINKES), was attended by 25 national companies from various sectors. The award was given to companies that have contributed to ATM control efforts over the past three years.
‘This award from ADINKES is a form of appreciation for Kalbe's commitment to improving the nation's health. Through its products and services, Kalbe continues to deliver innovations that benefit the community, particularly in supporting the control of ATM diseases,’ explained Abi Nisaka.
Over the past three years, Kalbe has donated medicines and vitamins worth more than one billion rupiah to support the prevention and control of NCDs.
Meanwhile, Kalbe Corporate Sustainability Assistant Manager SFD Arie Wibowo said that support and collaboration with various stakeholders are essential in supporting the eradication of NCDs.
‘We express our highest appreciation to various stakeholders, including the East Jakarta Health Office, which has collaborated with Kalbe in supporting efforts to eradicate ATM, especially in the East Jakarta area,’ explained Arie.
The awards received by Kalbe demonstrate Kalbe's commitment and enthusiasm for sustainability.